Resources
Case studies, publications, and dashboard how-tos from trials we have run.
Spotlight
What happens before the sample hits the cytometer
Fresh-X compared fresh, cryopreserved, and TokuKit-fixed whole blood across the same draws. Fixation held populations that freezing lost.
Latest news
All newsTeiko will collaborate with University of Utah Health on developing a series of immune profiling tests, starting with Acute Myeloid Leukemia
Teiko has partnered with University of Utah Health and Huntsman Cancer Institute to develop advanced immune profiling tests, beginning with Acute Myeloid Leukemia (AML). By using Teiko's TokuKit and advanced multiparameter assays the collaboration aims to expand access to high-precision MRD testing for community and rural healthcare settings.
Teiko to present new AML MRD and long-term whole blood stabilization research at ICCS 2026
Teiko is presenting two posters at ICCS 2026: one on stabilizing bone marrow aspirates for AML MRD testing and another on 24-month whole blood stabilization preserving immune phenotypes.
Teiko launches rapid, low-cost configurable cytometry assays for clinical immune monitoring
Teiko announces the launch of rapid, low-cost configurable cytometry assays for clinical immune monitoring, offering sponsors over 12K pre-validated configurations run in days at mid-hundreds per sample.
Proof from trials
All case studiesPublished work
All publicationsTeiko Studies
All studiesSTUDY
Cyto-Chex yields decreased B cell frequencies and increased double-positive T cell frequencies after 7 days. Transfix sees a loss of T-bet expression.
STUDY
From 0.5 mL to 3 mL blood inputs, TokuKit preserves immune cell populations within +/-2% of the standard 2 mL blood volume.
STUDY
